These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28202613)

  • 1. The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β
    Thiruchelvam-Kyle L; Hoelsbrekken SE; Saether PC; Bjørnsen EG; Pende D; Fossum S; Daws MR; Dissen E
    J Immunol; 2017 Apr; 198(7):2556-2567. PubMed ID: 28202613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel antibody combination to identify KIR2DS2
    Blunt MD; Rettman P; Bastidas-Legarda LY; Fulton R; Capizzuto V; Naiyer MM; Traherne JA; Khakoo SI
    HLA; 2019 Jan; 93(1):32-35. PubMed ID: 30381896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors.
    Warren HS; Campbell AJ; Waldron JC; Lanier LL
    Int Immunol; 2001 Aug; 13(8):1043-52. PubMed ID: 11470774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.
    Moesta AK; Parham P
    Front Immunol; 2012; 3():336. PubMed ID: 23189078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
    Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
    J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
    Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
    Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2.
    Vitale M; Carlomagno S; Falco M; Pende D; Romeo E; Rivera P; Della Chiesa M; Mavilio D; Moretta A
    Int Immunol; 2004 Oct; 16(10):1459-66. PubMed ID: 15314042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
    Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
    J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.
    Ayo CM; Reis PG; Dalalio MM; Visentainer JE; Oliveira Cde F; de Araújo SM; de Oliveira Marques DS; Sell AM
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003753. PubMed ID: 25978047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
    Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
    Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.
    Martínez-Losada C; Martín C; Gonzalez R; Manzanares B; García-Torres E; Herrera C
    Front Immunol; 2017; 8():810. PubMed ID: 28751893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).
    Saulquin X; Gastinel LN; Vivier E
    J Exp Med; 2003 Apr; 197(7):933-8. PubMed ID: 12668644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
    Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
    J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.